Catalent Pharma Solutions, Inc.
company.status.inactiveCIK 1416083fmd_14NR1ZSQ4DB321GGWP4CRTPE7QManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2009 to Mar 31, 2014, 16 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|
| Total revenues | 1,480 | 1,532 | 1,695 | 1,800 |
| Cost of revenue | 1,040 | 1,030 | 1,136 | 1,232 |
| Net interest income | (161) | (166) | (183) | (203) |
| Gross profit | 441 | 502 | 559 | 569 |
| Selling, general and administrative | 270 | 288 | 348 | 341 |
| Operating income | (62) | 186 | 198 | 204 |
| Other non-operating income (expense) | 7 | (26) | 4 | (25) |
| Income before taxes | 215 | (5) | 19 | (24) |
| Income tax expense | 22 | 24 | 17 | 24 |
| Net income from continuing operations | (237) | (29) | 2 | (48) |
| Net income | (290) | (54) | (40) | (47) |